International Society of Liquid Biopsy

Latest Content

Please check back later for more content.

Trending on Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways

A Look Inside CONVERGE: Intratumoral Therapy Comes to Locally Advanced NSCLC

DiBardino Outlines Phase 2 CONVERGE Trial Design of Radioenhancer in NSCLC

FDA Approves Imlunestrant Plus Abemaciclib in ESR1-Mutated Breast Cancer

Taletrectinib Sustains Durable ROS1+ NSCLC Responses at 3-Year Follow-Up

FDA Launches Expedited IND Pilot to Speed First-in-Human Trials